ES2183223T3 - Composicion para uso veterinario intramamaria que no contiene agentes antiinflamatorios. - Google Patents

Composicion para uso veterinario intramamaria que no contiene agentes antiinflamatorios.

Info

Publication number
ES2183223T3
ES2183223T3 ES97949079T ES97949079T ES2183223T3 ES 2183223 T3 ES2183223 T3 ES 2183223T3 ES 97949079 T ES97949079 T ES 97949079T ES 97949079 T ES97949079 T ES 97949079T ES 2183223 T3 ES2183223 T3 ES 2183223T3
Authority
ES
Spain
Prior art keywords
intramamary
composition
inflammatory agents
veterinary use
contain anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97949079T
Other languages
English (en)
Other versions
ES2183223T5 (es
Inventor
Vincent Mcnally
James Patrick Morgan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zoetis Broomhill IP Ltd
Original Assignee
Bimeda Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11041329&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2183223(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bimeda Research and Development Ltd filed Critical Bimeda Research and Development Ltd
Publication of ES2183223T3 publication Critical patent/ES2183223T3/es
Application granted granted Critical
Publication of ES2183223T5 publication Critical patent/ES2183223T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01J—MANUFACTURE OF DAIRY PRODUCTS
    • A01J7/00—Accessories for milking machines or devices
    • A01J7/04—Accessories for milking machines or devices for treatment of udders or teats, e.g. for cleaning
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Environmental Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Una formulación exenta de agentes antiinflamatorios para el tratamiento preventivo de mastitis en vacas secas que comprende una formulación de sellado que tiene aproximadamente un 65% en peso de un subnitrato de bismuto en un gel a base de estearato de aluminio. Una formulación exenta de agentes antiinflamatorios para el tratamiento preventivo de mastitis en vacas secas. La formulación de sellado se prepara añadiendo el subnitrato de bismuto a la base del gel en al menos dos etapas separadas.
ES97949079.4T 1996-12-18 1997-12-17 Composición intramamaria para uso veterinario que no contiene agentes antiinflamatorios Expired - Lifetime ES2183223T5 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IE960896 1996-12-18
IE960896 1996-12-18
PCT/IE1997/000085 WO1998026759A1 (en) 1996-12-18 1997-12-17 Antiinfective free intramammary veterinary composition

Publications (2)

Publication Number Publication Date
ES2183223T3 true ES2183223T3 (es) 2003-03-16
ES2183223T5 ES2183223T5 (es) 2015-05-07

Family

ID=11041329

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97949079.4T Expired - Lifetime ES2183223T5 (es) 1996-12-18 1997-12-17 Composición intramamaria para uso veterinario que no contiene agentes antiinflamatorios

Country Status (16)

Country Link
US (9) US6254881B1 (es)
EP (1) EP0971690B2 (es)
JP (1) JP4328886B2 (es)
AT (1) ATE223201T1 (es)
AU (1) AU724518B2 (es)
BR (1) BR9714935A (es)
CA (1) CA2274796C (es)
DE (1) DE69715259T3 (es)
DK (1) DK0971690T4 (es)
ES (1) ES2183223T5 (es)
GB (1) GB2334886B (es)
IE (1) IE970892A1 (es)
NZ (1) NZ336153A (es)
PT (1) PT971690E (es)
WO (1) WO1998026759A1 (es)
ZA (1) ZA9711362B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0971690T4 (en) * 1996-12-18 2015-07-13 Bimeda Res & Dev Ltd Anti-infective intramammary veterinary composition.
AU2002334349B2 (en) * 2001-09-10 2008-05-15 Bimeda Research & Development Limited A bio-security system
SE524623C2 (sv) * 2002-08-08 2004-09-07 Bofors Defence Ab Isolerad patronhylsa och ammunition, förfarande för tillverkning av dylika hylsor och ammunition samt användning av dylika hylsor och ammunition vid flera skilda vapensystem
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
GB0229642D0 (en) * 2002-12-20 2003-01-22 Pfizer Ltd Veterinary compositions for treating mastitis
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
NZ548748A (en) 2004-02-02 2010-09-30 Bimeda Res & Dev Ltd Method and device for treating a teat canal of an animal
US7828765B2 (en) 2004-02-02 2010-11-09 Bimeda Research & Development Ltd Method and device for administering two components into the teat canal of a non-human animal
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
CA2616204C (en) * 2005-09-09 2015-12-01 Labopharm Inc. Sustained drug release composition
NZ576223A (en) 2006-10-10 2012-04-27 Wisconsin Alumni Res Found Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
AU2013202381B2 (en) * 2006-10-10 2016-05-05 Wisconsin Alumni Research Foundation Intra-mammary teat sealant formulation and method of using same to reduce or eliminate visual defects in aged cheeses
NZ571347A (en) 2008-09-17 2010-04-30 Mastitis Res Ct Ltd Anti-infective formulation and methods of use
AU2009320504A1 (en) * 2008-11-28 2011-07-07 Mastitis Research Centre Limited Animal treatment formulation and methods of use
EP3158868A1 (en) * 2008-12-04 2017-04-26 Merial, Inc Intramammary teat sealant
JP5773983B2 (ja) 2009-04-08 2015-09-02 ウィスコンシン アルムニ リサーチ ファンデイション 乳房内乳頭シール剤及びその熟成チーズの外観上の欠陥を減少又は除去のための使用
AU2014318264B2 (en) 2013-09-16 2018-10-04 Zoetis Services Llc Assembly for sequentially delivering substances, and associated methods
BR112017022768B1 (pt) 2015-04-24 2022-05-17 Sanuwave, Inc Aplicador de onda de choque de pressão acústica
PT3368082T (pt) 2015-10-29 2020-11-11 Zoetis Broomhill Ip Ltd Formulação de vedante de tetos
RU2761212C2 (ru) 2015-11-03 2021-12-06 Зоэтис Сервисиз Ллс Полимерные композиты, полученные по способу золь-гель, и их применение
EP3612155A1 (en) 2017-04-20 2020-02-26 Zoetis Services LLC Veterinary compositions for use in treating mastitis, and associated methods
CA3066243A1 (en) 2017-06-09 2018-12-13 Zoetis Broomhill Ip Limited Intramammary veterinary composition
US20190167714A1 (en) 2017-12-01 2019-06-06 Zoetis Services Llc Hydrogel compositions and uses thereof
EP3740156A1 (en) * 2018-01-18 2020-11-25 Zoetis Broomhill IP Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
EP3513767A1 (en) * 2018-01-18 2019-07-24 Bimeda Research & Development Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
GR1010072B (el) 2019-05-15 2021-09-15 Αριστοτελειο Πανεπιστημιο Θεσσαλονικης - Ειδικος Λογαριασμος Κονδυλιων Ερευνας Βρωσιμα κτηνιατρικα σκευασματα ενδομαστικης προστασιας θηλαστικων και μεθοδος για την παρασκευη τους

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB792545A (en) 1955-07-27 1958-03-26 Novo Terapeutisk Labor As Manufacture of antibiotic preparations having a protracted effect
US3222252A (en) 1962-11-01 1965-12-07 Heinz J Kraus Preparation and method for the prevention, treatment, and control of mastitis in bovine udders
GB1312918A (en) 1969-07-08 1973-04-11 Beecham Group Ltd Veterinary treatment
GB1441747A (en) * 1972-10-18 1976-07-07 Lazonby B Veterinary compositions
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
CA1052697A (en) 1974-03-29 1979-04-17 Upjohn Company (The) Composition for treating mastitis in animals
US4049830A (en) * 1974-11-13 1977-09-20 Milmark Research, Inc. Bovine teat dip
GB1547164A (en) 1975-08-14 1979-06-06 Beecham Group Ltd Veterinary compositions
US4022199A (en) 1975-09-24 1977-05-10 Fetty Walter W Method of preventing the spread and control of mastitis
US4113854A (en) 1977-01-10 1978-09-12 Minnesota Mining And Manufacturing Company Prophylactic treatment of mastitis
US4172138A (en) * 1977-03-23 1979-10-23 Rhodes Russell E Method and composition of matter for the treatment of dry cows for mastitis
IE49770B1 (en) 1979-05-21 1985-12-11 Leo Pharm Prod Ltd 6beta-halopenicillanic acid derivatives
US4344967A (en) * 1979-08-07 1982-08-17 Devro, Inc. Film forming composition and uses thereof
EP0076068A3 (en) 1981-09-25 1985-05-15 Beecham Group Plc Intramammary veterinary compositions and method for their use
IE53610B1 (en) 1981-12-14 1988-12-21 Merck & Co Inc Waterless thixotropic composition
GB8629481D0 (en) * 1986-12-10 1987-01-21 Beecham Group Plc Veterinary treatment
US5017369A (en) 1987-03-03 1991-05-21 Marhevka Virginia C Film-forming teat sealer for prevention of mastitis and use thereof
US5195966A (en) * 1987-12-24 1993-03-23 Diversey Limited Treatment of mastitis and applicator therefor
US5593384A (en) * 1989-03-23 1997-01-14 Halem; Stephen H. Controlled infusion administration of pharmaceuticals
CA2041774C (en) * 1990-11-27 1994-04-19 Mircea A. Mateescu Use of cross-linked amylose as a matrix for the slow release of biologically active compounds
JPH0660104B2 (ja) 1990-12-17 1994-08-10 鈴木 忠 乳牛の乳房炎に対する治療剤
RU2028798C1 (ru) 1991-04-08 1995-02-20 Институт животноводства УААН Способ профилактики мастита у коров
WO1995031180A1 (en) 1992-12-08 1995-11-23 Bimeda Research And Development Limited A veterinary composition
DK0673239T3 (da) 1992-12-08 1999-03-22 Bimeda Res Dev Ltd Vandig antibiotisk sammensætning til veterinær anvendelse
JP3288550B2 (ja) 1994-05-02 2002-06-04 オーバーシーズ ファーマテック株式会社 ヘリコバクター・ピロリ菌殺菌のための局所用口腔内投与剤
US5529770A (en) 1994-12-09 1996-06-25 West Agro, Inc. Viscous liquid conditioning topical germicides
DE19502629C2 (de) 1995-01-19 1998-11-05 Grace Gmbh Verwendung einer Zusammensetzung auf Basis von polyolbehandeltem Siliciumdioxid als Antiblockingmittel
JP4111999B2 (ja) 1995-02-01 2008-07-02 デュラセル、インコーポレーテッド スラリ製造方法
JP3851371B2 (ja) 1995-02-25 2006-11-29 久光製薬株式会社 非水系油性軟膏基剤及び皮膚外用軟膏剤
DK0971690T4 (en) * 1996-12-18 2015-07-13 Bimeda Res & Dev Ltd Anti-infective intramammary veterinary composition.
US6107344A (en) * 1999-02-16 2000-08-22 Webco Chemical Corporation Aqueous germicidal film forming composition for applying to teats of dairy cows
US20050192547A1 (en) * 2002-01-31 2005-09-01 Modak Shanta M. Combinations of antiseptic and antibiotic agents containing medical devices
US20040197422A1 (en) * 2002-12-20 2004-10-07 Pfizer Inc Veterinary compositions for treating mastitis

Also Published As

Publication number Publication date
WO1998026759A1 (en) 1998-06-25
US6254881B1 (en) 2001-07-03
US20050175713A1 (en) 2005-08-11
JP4328886B2 (ja) 2009-09-09
AU724518B2 (en) 2000-09-21
EP0971690A1 (en) 2000-01-19
EP0971690B1 (en) 2002-09-04
US20110268819A1 (en) 2011-11-03
DE69715259T3 (de) 2015-08-20
US6340469B1 (en) 2002-01-22
GB9913953D0 (en) 1999-08-18
BR9714935A (pt) 2000-10-03
US20170196909A1 (en) 2017-07-13
DK0971690T4 (en) 2015-07-13
ZA9711362B (en) 1998-08-28
US8758831B2 (en) 2014-06-24
PT971690E (pt) 2002-12-31
JP2001506648A (ja) 2001-05-22
DK0971690T3 (da) 2002-12-23
ES2183223T5 (es) 2015-05-07
GB2334886A (en) 1999-09-08
IE970892A1 (en) 2000-02-09
CA2274796A1 (en) 1998-06-25
ATE223201T1 (de) 2002-09-15
NZ336153A (en) 2000-06-23
US6506400B1 (en) 2003-01-14
US20100055202A1 (en) 2010-03-04
DE69715259D1 (de) 2002-10-10
GB2334886B (en) 2000-08-23
US20030235625A1 (en) 2003-12-25
CA2274796C (en) 2006-12-05
AU7735198A (en) 1998-07-15
EP0971690B2 (en) 2015-04-01
DE69715259T2 (de) 2003-08-07
US20150051300A1 (en) 2015-02-19

Similar Documents

Publication Publication Date Title
ES2183223T3 (es) Composicion para uso veterinario intramamaria que no contiene agentes antiinflamatorios.
AU1666188A (en) Deodorizing and antimicrobial composition for use in cosmetic or topical formulations
IT1227154B (it) Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
CA2063576A1 (en) Slow release vehicles for minimizing skin irritancy of topical compositions
IL78175A0 (en) Azolylmethyloxiranes,their preparation and their use as crop protection agents
MX9603560A (es) Composiciones de prostaglandinas estables en almacenamiento.
AR240929A1 (es) "n-piridinsulfonil-n'-piridinil-y-triazinil-ureas procedimiento parasu preparacion, intermediarios para uso exclusivo en dicho procedimiento, y composiciones que contienen dichas ureas"
YU47204B (sh) Derivati didehidro-vitamina d3
ES2063097T3 (es) Inhibidor de la glicosidasa salbostatina, procedimiento para su preparacion y su empleo.
AR228245A1 (es) 3-(2,2-dihaloetenil)-2,2-dimetilciclopropanocarboxilato,excepto cuando esta destinado para aplicacion sobre o en el hombre y animales superiores;formulacion plaguicida en base a dicho compuesto;y un compuesto de(1,1-bifenil)-3-ilmetilo sustituido destinado exclusivamente como intermediario para la preparacion de dicho compuesto
AU531057B2 (en) 6beta,7beta,15,16-dimethylene-1,4-androstadien-3-ones
KR870000072A (ko) 아졸 유도체를 함유하는 제제물 및 외상없이 손톱을 제거하기 위한 그 용도
BG103325A (en) Analgetic preparation for external application
HUP9800832A2 (hu) Transzdermális formulált alak
ATE221780T1 (de) Fenbendazolformulierungen
DE69221150D1 (de) Pharmakologisch verbesserte formulierungen
ES2169779T3 (es) Procedimiento para la preparacion de poli(diorganosiloxanos), composiciones que contienen los mismos y su uso.
CA2094090A1 (en) Thixotropic formulations
IT1255076B (it) Microsfere biodegradabili ad uso farmaceutico e cosmetico
IE831863L (en) Fatty acid compositions.
ES511730A0 (es) "un procedimiento para la preparacion de oxaprocin calcico".
AR240400A1 (es) Procedimiento para obtener nuevas composiciones sinergicas para uso veterinario.
EP0113009A3 (de) Antimykotische Mittel mit hoher Wirkstoff-Freisetzung in Form von Gelsystemen
IE800344L (en) Anti-perspirant compositions
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso